Table PDU-1 part (ii). Prevalence of problem drug use at national level and range in local estimates, 1999 to 2003: summary table (rate per 1000 aged 15 to 64). Injecting drug use

Country

 

Year

 

Method

 

Rate per 1000
(95% CI (1) or SI)

 

Numbers

 

Data sources/comments

 

Reference

 

Range in local estimates rate per 1000 (midpoints)

Lowest estimate (year/method/region)

Highest estimate (year/method/region)

Germany

2000

MM

(2.27-3.03)

(126875-169167)

Police.

2, 4, 6, 99

 

 

2000

HM

(1.61-2.83)

(90000-158000)

Treatment monitoring system: outpatient

2, 5, 6, 99

 

 

Greece

2003

CR

1.29 (1.08-1.56)*

9626 (8044-11607)

Treatment demands at other services.

3

2.15 (2) (2003/CR/Greater Athens)

2.15 (2) (2003/CR/Greater Athens)

France

1999

HM

3.20

122000

Method not based on HIV but on use of syringes and substitution substance.

2

 

 

Italy

 

  

  

  

  

 

6.7 (1999/(3)/South Region)

8.1 (1999/(3)/Center Regions)

Luxembourg

2000

HM

5.89

1715

 

2, 99

 

 

Austria

2000

MM

(2.19-4.19)

(12000-23000)

 

1, 99

 

 

Portugal

2000

MM

(2.30-4.60)

(15900-31800)

IDUs or regular/long time users of opiates, cocaine and/or amphetamines. Ministry of Justice/National Forensic Medicine Institute/data from the Special Register on drug-related deaths

1, 99

 

 

2000

HM

(4.28-6.35)

(29620-43966)

IDUs diagnosed with HIV/AIDS and registered in prisons, therapeutic communities, social services, drop-in centres and health centres

1, 99

 

 

UK

2001

CM

3,2

123498

 

2, 3, 4, 5

0.07 (2003/CR/Dundee)

13.7 (2001/CR/Brighton)

Norway

2002

MM

(3.71-5.10)

(11000-15000)

 

1

 

 

                     

Notes                    

(1) 95% confidence interval (CI); intervals from sensitivity analysis (SI) are not marked with asterisk.           

See [Table PDU-0] for details on bibliographic references.

For further details on methods and data sources/comments see [Table PDU-3] and [Table PDU-4].      

(2) Midpoints have been calculated in cases where no central estimate was provided to facilitate interpretation and comparisons; these are presented with an asterisk.

(3) Mortality multiplier, multivariate indicator and treatment multiplier.      

Data filter | pdutab02b-en.xml